221 related articles for article (PubMed ID: 24311705)
21. Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study.
Garimella PS; Katz R; Patel KV; Kritchevsky SB; Parikh CR; Ix JH; Fried LF; Newman AB; Shlipak MG; Harris TB; Sarnak MJ;
Circ Heart Fail; 2016 Jan; 9(1):e002124. PubMed ID: 26721912
[TBL] [Abstract][Full Text] [Related]
22. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome, ESRD, and death in CKD.
Navaneethan SD; Schold JD; Kirwan JP; Arrigain S; Jolly SE; Poggio ED; Beddhu S; Nally JV
Clin J Am Soc Nephrol; 2013 Jun; 8(6):945-52. PubMed ID: 23411425
[TBL] [Abstract][Full Text] [Related]
24. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
[TBL] [Abstract][Full Text] [Related]
25. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
Chiu DY; Kalra PA; Sinha S; Green D
Nephrology (Carlton); 2016 Jun; 21(6):476-82. PubMed ID: 26426983
[TBL] [Abstract][Full Text] [Related]
26. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
27. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.
Trivin C; Metzger M; Haymann JP; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Stengel B; Thervet E;
Clin J Am Soc Nephrol; 2015 Jun; 10(6):957-64. PubMed ID: 25979978
[TBL] [Abstract][Full Text] [Related]
28. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
29. Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction.
Sulemane S; Panoulas VF; Bratsas A; Grapsa J; Brown EA; Nihoyannopoulos P
Int J Cardiovasc Imaging; 2017 May; 33(5):687-698. PubMed ID: 28120157
[TBL] [Abstract][Full Text] [Related]
30. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
Tatami Y; Yasuda Y; Suzuki S; Ishii H; Sawai A; Shibata Y; Ota T; Shibata K; Niwa M; Morimoto R; Hayashi M; Kato S; Maruyama S; Murohara T
Atherosclerosis; 2015 Dec; 243(2):349-55. PubMed ID: 26519631
[TBL] [Abstract][Full Text] [Related]
31. Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.
Sjöberg B; Qureshi AR; Heimbürger O; Stenvinkel P; Lind L; Larsson A; Bárány P; Ärnlöv J
J Intern Med; 2016 Feb; 279(2):173-9. PubMed ID: 26355706
[TBL] [Abstract][Full Text] [Related]
32. Serum surfactant protein D is associated with the prognosis in patients with chronic kidney disease.
Xie F; Wang X; Ding Z; Fan P; Fan L; Chen Z; Ma G
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):461-5. PubMed ID: 23314596
[TBL] [Abstract][Full Text] [Related]
33. Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease.
Perkins RM; Tang X; Bengier AC; Kirchner HL; Bucaloiu ID
Kidney Int; 2012 Dec; 82(12):1332-8. PubMed ID: 22874841
[TBL] [Abstract][Full Text] [Related]
34. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
[TBL] [Abstract][Full Text] [Related]
35. Vascular calcification in patients with nondialysis CKD over 3 years.
Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
[TBL] [Abstract][Full Text] [Related]
36. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
37. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.
Obokata M; Negishi K; Sunaga H; Ishida H; Ito K; Ogawa T; Iso T; Ando Y; Kurabayashi M
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974498
[TBL] [Abstract][Full Text] [Related]
38. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
[TBL] [Abstract][Full Text] [Related]
39. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.
Rivera-Caravaca JM; Ruiz-Nodar JM; Tello-Montoliu A; Esteve-Pastor MA; Quintana-Giner M; Véliz-Martínez A; Orenes-Piñero E; Romero-Aniorte AI; Vicente-Ibarra N; Pernias-Escrig V; Carrillo-Alemán L; Candela-Sánchez E; Hortelano I; Villamía B; Sandín-Rollán M; Nuñez-Martínez L; Valdés M; Marín F
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680822
[TBL] [Abstract][Full Text] [Related]
40. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
